{"id":"W3136212749","doi":"10.1016/j.ejca.2021.01.053","title":"Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Cancer Society; National Institutes of Health; Novartis Pharmaceuticals Corporation; GlaxoSmithKline","keywords":"Lapatinib; Medicine; Trastuzumab; Internal medicine; Hazard ratio; Breast cancer; Chemotherapy; Oncology; Gastroenterology; Confidence interval; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007919611,0.001466529,0.00288565,0.0006947939,0.0004489776,0.002901585,0.001238072,0.00146906,0.01830877],"category_scores_gemma":[0.009887285,0.000507417,0.003347575,0.001268014,0.0003794511,0.002207445,0.001122202,0.003988666,0.004810538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001302817,"about_ca_system_score_gemma":0.001760839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0019795,"about_ca_topic_score_gemma":0.006527306,"domain_scores_codex":[0.9971847,0.001326696,0.000229788,0.0002767715,0.0006188604,0.0003632116],"domain_scores_gemma":[0.9948807,0.001811052,0.001019874,0.0005896527,0.0009142383,0.0007845479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1356575,0.001139545,0.009225604,0.004597808,0.006940954,0.0002316684,0.0001229772,0.00242267,0.003446923,0.001462959,0.5387243,0.2960271],"study_design_scores_gemma":[0.2036824,0.01897366,0.09566194,0.00249522,0.02310384,0.001315897,0.0001734676,0.001920211,0.003132107,0.010343,0.6388884,0.0003098017],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"empirical","genre_scores_codex":[0.1784758,0.2219249,0.01369385,0.0691021,0.02509826,0.004473381,0.3540731,0.003156952,0.1300018],"genre_scores_gemma":[0.3927609,0.04922669,0.02284883,0.08208703,0.01234794,0.006059743,0.3821903,0.001544478,0.05093403],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01830877,"threshold_uncertainty_score":0.06124902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1183897931597474,"score_gpt":0.4161039780804137,"score_spread":0.2977141849206663,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}